Zefway 200 DT Tablet is a combination antibiotic formulation containing Cefixime 200 mg and Lactobacillus 60 million spores, designed for the effective treatment of bacterial infections while supporting gastrointestinal flora balance. Cefixime, a third-generation cephalosporin antibiotic, exhibits broad-spectrum activity against various gram-positive and gram-negative bacteria by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. It is commonly prescribed for infections such as urinary tract infections, respiratory tract infections, otitis media, and uncomplicated gonorrhea. The inclusion of Lactobacillus, a probiotic, helps maintain and restore the natural intestinal flora disrupted by antibiotic therapy, thereby reducing the risk of antibiotic-associated diarrhea and promoting gut health. Zefway 200 DT is formulated as a dispersible tablet, facilitating ease of administration and rapid onset of action, especially beneficial for pediatric and geriatric patients who may have difficulty swallowing conventional tablets. It is important to use this medication under medical supervision, adhering to prescribed dosages and duration to prevent the development of resistance and ensure therapeutic efficacy. Patients with known hypersensitivity to cephalosporins or probiotics should avoid this medication. Common side effects may include gastrointestinal disturbances such as nausea, diarrhea, or abdominal discomfort.